Literature DB >> 6443151

Elevated levels of amino acids in the CSF of motor neuron disease patients.

J de Belleroche, A Recordati, F C Rose.   

Abstract

Amino acid levels in the cerebrospinal fluid of patients with motor neuron disease were compared with an age-matched control group receiving diagnostic myelography. Five amino acids were significantly elevated in the cerebrospinal fluid of the motor neuron disease patients compared to the controls. These were isoleucine, glycine, alanine, phenylalanine, and threonine, which were increased by 60, 58, 38, 26, and 25% respectively. A significant increase was also obtained when the amino acids with nonpolar R groups were grouped together (34%). The significance of these findings is discussed in terms of amino acid changes that occur in both normal aging and other neurological conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6443151     DOI: 10.1007/bf02834167

Source DB:  PubMed          Journal:  Neurochem Pathol        ISSN: 0734-600X


  7 in total

1.  Involvement of NMDA receptor in the modulation of excitatory and inhibitory amino acid neurotransmitters release in cortical neurons.

Authors:  E López; J Hernandez; C Arce; S Cañadas; M J Oset-Gasque; M P González
Journal:  Neurochem Res       Date:  2010-06-12       Impact factor: 3.996

2.  Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.

Authors:  S Malessa; P N Leigh; O Bertel; E Sluga; O Hornykiewicz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

3.  The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.

Authors:  L J Herberg; I C Rose
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Abnormal glycine metabolism in motor neurone disease: studies on plasma and cerebrospinal fluid.

Authors:  R J Lane; R Bandopadhyay; J de Belleroche
Journal:  J R Soc Med       Date:  1993-09       Impact factor: 5.344

5.  Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.

Authors:  Charlotte Veyrat-Durebex; Philippe Corcia; Eric Piver; David Devos; Audrey Dangoumau; Flore Gouel; Patrick Vourc'h; Patrick Emond; Frédéric Laumonnier; Lydie Nadal-Desbarats; Paul H Gordon; Christian R Andres; Hélène Blasco
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 6.  The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS).

Authors:  Praveen Paul; Jackie de Belleroche
Journal:  Front Synaptic Neurosci       Date:  2014-04-16

Review 7.  Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?

Authors:  Jan Lewerenz; Pamela Maher
Journal:  Front Neurosci       Date:  2015-12-16       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.